Personalized E-Coaching in Cardiovascular Risk Reduction: A Randomized Controlled Trial.


Journal

Annals of global health
ISSN: 2214-9996
Titre abrégé: Ann Glob Health
Pays: United States
ID NLM: 101620864

Informations de publication

Date de publication:
12 07 2019
Historique:
entrez: 13 7 2019
pubmed: 13 7 2019
medline: 9 4 2020
Statut: epublish

Résumé

To assess whether electronic (e-) coaching, using personalized web-based lifestyle and risk factor counselling with additional email prompts, provides additional risk reduction when added to standard of care (SOC) in individuals at increased risk. Between June 2013 and May 2015, 402 participants were allocated 1:1 to e-coaching and SOC versus SOC. Participants free of manifest cardiovascular disease, with internet access, and a 10-year QRISK2 cardiovascular risk of ≥10% were enrolled. Change in oscillometric carotid-femoral pulse wave velocity (PWV) from baseline to six months was the primary endpoint. Secondary outcomes included change in blood pressure (BP), weight, and risk scores. Analysis was by intention to treat. Mean (±SD) age was 65.5 (5.6) years with 37% females. Primary outcome data were available for 94%. There was no difference in PWV reductions between e-coaching and standard of care groups (-0.16 m/s vs. -0.25 m/s, 95% confidence interval -0.39 to 0.22, p = 0.56). There were no differences in the improvement between groups for BP, weight, Framingham, or QRISK2 scores. Pulse wave velocity change was more favorable in those with a higher level of education (p = 0.04), but was not associated with age, gender, presence of diabetes, baseline QRISK2 score, or logins to the website. In individuals at increased cardiovascular risk, a comprehensive 'health check' program modestly reduced future risk. Personalized e-coaching did not provide added risk reduction. Currently there is no evidence to routinely recommend e-coaching in cardiovascular health check programs. HAPPY London ClinicalTrials.gov: NCT01911910.

Identifiants

pubmed: 31298823
doi: 10.5334/aogh.2496
pmc: PMC6634325
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT01911910']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIH
Pays : International

Informations de copyright

© 2019 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. See http://creativecommons.org/licenses/by/4.0/.

Déclaration de conflit d'intérêts

The authors have no competing interests to declare.

Références

J Cardiopulm Rehabil Prev. 2014 Sep-Oct;34(5):303-17
pubmed: 25079147
Hypertension. 2012 Aug;60(2):518-22
pubmed: 22733473
Ann Behav Med. 2006 Jun;31(3):205-23
pubmed: 16700634
J Biomed Eng. 1993 May;15(3):221-8
pubmed: 8320981
Hypertension. 1995 Sep;26(3):485-90
pubmed: 7649586
Int J Behav Nutr Phys Act. 2009 Jun 03;6:30
pubmed: 19490649
Health Technol Assess. 2012;16(38):1-205, iii-v
pubmed: 23046909
PLoS One. 2012;7(12):e50032
pubmed: 23251355
Health Educ Res. 2009 Aug;24(4):699-720
pubmed: 19286893
Heart. 2014 Apr;100 Suppl 2:ii1-ii67
pubmed: 24667225
Cochrane Database Syst Rev. 2011 Jan 19;(1):CD001561
pubmed: 21249647
BMJ. 2008 Jun 28;336(7659):1475-82
pubmed: 18573856
Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):243-52
pubmed: 25414255
J Hum Hypertens. 2008 Oct;22(10):678-86
pubmed: 18432253
Circulation. 2015 Sep 22;132(12):1157-213
pubmed: 26271892
Circulation. 2001 Feb 20;103(7):987-92
pubmed: 11181474
Heart. 2008 Oct;94(10):1331-2
pubmed: 18701534
Glob Heart. 2011 Dec;6(4):221-2
pubmed: 25691050
Circulation. 2005 Jun 28;111(25):3384-90
pubmed: 15967850
Atherosclerosis. 2012 Jul;223(1):1-68
pubmed: 22698795
Int J Cardiol. 2018 Jul 15;263:142-151
pubmed: 29754910
Lancet. 2004 Sep 11-17;364(9438):937-52
pubmed: 15364185
Prev Med. 2010 Sep-Oct;51(3-4):214-21
pubmed: 20558196
JAMA. 2016 Sep 20;316(11):1161-1171
pubmed: 27654602
Ann Intern Med. 2016 Nov 15;165(10):713-722
pubmed: 27618509
Mayo Clin Proc. 2015 Apr;90(4):469-80
pubmed: 25841251

Auteurs

Mohammed Y Khanji (MY)

Centre for Advanced Cardiovascular Imaging and Research, William Harvey Research Institute, Queen Mary University of London, UK.
Barts Health NHS Trust, London, UK.

Armida Balawon (A)

Centre for Advanced Cardiovascular Imaging and Research, William Harvey Research Institute, Queen Mary University of London, UK.

Redha Boubertakh (R)

Centre for Advanced Cardiovascular Imaging and Research, William Harvey Research Institute, Queen Mary University of London, UK.
Barts Health NHS Trust, London, UK.

Leonard Hofstra (L)

Cardiologie Centra Nederland, Utrecht, NL.

Jagat Narula (J)

Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, US.

Myriam Hunink (M)

Department of Clinical Epidemiology and Radiology, Erasmus MC, Rotterdam, NL.
Center for Health Decision Sciences, Harvard T.H. Chan School of Public Health, Boston, MA, US.

Francesca Pugliese (F)

Centre for Advanced Cardiovascular Imaging and Research, William Harvey Research Institute, Queen Mary University of London, UK.
Barts Health NHS Trust, London, UK.

Steffen E Petersen (SE)

Centre for Advanced Cardiovascular Imaging and Research, William Harvey Research Institute, Queen Mary University of London, UK.
Barts Health NHS Trust, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH